Literature DB >> 7960979

Long-term follow-up of young children with brain tumors after irradiation.

I Syndikus1, D Tait, S Ashley, L Jannoun.   

Abstract

PURPOSE: Young children with brain tumors are at high risk of developing late sequelae after curative radiotherapy. A retrospective study was undertaken to determine the frequency and severity of neurological deficits, endocrine dysfunction, and intellectual disabilities. METHODS AND MATERIAL: One hundred and fifty-six children age < or = 3 years were treated between 1952 and 1986 with radiotherapy. Of the 57 survivors, 47 had surgery, 12 chemotherapy and 24 children received cranio-spinal radiotherapy. Late radiation side effects were assessed with a clinical examination, blood tests and an interview.
RESULTS: The median follow-up was 13 years and the actuarial survival at 5 and 10 years was 49% and 44%, respectively. No, or only a mild, handicap was noted in 24 patients, while 21 had moderately severe and 16 severe disabilities. Children with supratentorial tumors had more abnormal neurological findings compared to those with infratentorial malignancies (p < 0.001). Eighty percent of children had endocrine abnormalities, which were more marked in children with parasellar tumors (p < 0.001). Twenty-one children were mentally retarded. In a multivariate analysis epilepsy emerged as the only significant variable independently associated with poor cognitive function.
CONCLUSION: Long-term morbidity was found to be disabling in 58% of the surviving children. These findings encourage the development of treatment strategies designed to reduce toxicity.

Entities:  

Mesh:

Year:  1994        PMID: 7960979     DOI: 10.1016/0360-3016(94)90349-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Common brain tumours in children: diagnosis and treatment.

Authors:  E Bouffet
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Health status in 52 long-term survivors of pediatric brain tumors.

Authors:  N K Foreman; P M Faestel; J Pearson; J Disabato; M Poole; G Wilkening; E B Arenson; B Greffe; R Thorne
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 3.  A review of non-cancer effects, especially circulatory and ocular diseases.

Authors:  Mark P Little
Journal:  Radiat Environ Biophys       Date:  2013-08-01       Impact factor: 1.925

4.  Long-term functional outcome of suprasellar germinomas: usefulness and limitations of radiotherapy.

Authors:  H Oka; N Kawano; T Tanaka; S Utsuki; I Kobayashi; H Maezawa; K Fujii
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

Review 5.  Surviving childhood cancer: the impact on life.

Authors:  Robert E Goldsby; Denah R Taggart; Arthur R Ablin
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  Evolution of neurological impairment in pediatric infratentorial ependymoma patients.

Authors:  E Brannon Morris; Chenghong Li; Raja B Khan; Robert A Sanford; Frederick Boop; Renee Pinlac; Xiaoping Xiong; Thomas E Merchant
Journal:  J Neurooncol       Date:  2009-03-29       Impact factor: 4.130

Review 7.  Ionizing Radiation-Induced Epigenetic Modifications and Their Relevance to Radiation Protection.

Authors:  Mauro Belli; Maria Antonella Tabocchini
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

8.  Early postnatal irradiation-induced age-dependent changes in adult mouse brain: MRI based characterization.

Authors:  Bo Xu Ren; Isaac Huen; Zi Jun Wu; Hong Wang; Meng Yun Duan; Ilonka Guenther; K N Bhanu Prakash; Feng Ru Tang
Journal:  BMC Neurosci       Date:  2021-04-21       Impact factor: 3.288

Review 9.  Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques.

Authors:  Giuseppe Minniti; Marie-Lise Jaffrain-Rea; Mattia Osti; Giampaolo Cantore; Riccardo Maurizi Enrici
Journal:  Neurosurg Rev       Date:  2007-05-05       Impact factor: 2.800

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.